Fig. 1. In human gastric cancer, low expression of CDK5RAP3 is related to poor clinical prognosis and higher M2 content.
A The number of CD68+ and CD206+ cells in centre of the tumour (CT) and invasive margin (IM) sections of gastric cancer tissues in gastric cancer patients (n = 241) with different CDK5RAP3 expression levels. Data are presented as the mean ± SD and were analysed using Student’s t-test. B Kaplan–Meier analysis of RFS and OS in gastric cancer patients based on the expression of CDK5RAP3 in gastric cancer (n = 241). C Multiplex fluorescent immunohistochemistry of gastric cancer tissues. CKpan, DAPI, CD68, INOS, CD206 and CDK5RAP3. Scale bar = 100 μm. D Merged fluorescent immunohistochemical images showing the expression of CD206 and INOS in gastric cancer tissues with different expression levels of CDK5RAP3. Scale bar = 100 μm. E In 140 random fields of view, the number of tumour-associated macrophages (TAMs) subgroups with different expression levels of CDK5RAP3 is presented in the scatter plot. Error bars indicate estimated 95% CI (mean ± SD, n = 140). *P < 0.05; **P < 0.01; ***P < 0.001. P-values for all survival analyses were calculated using the log-rank test.